ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGEN Repligen Corp

167.86
-3.42 (-2.00%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 555,959
Bid Price 162.52
Ask Price 174.01
News -
Day High 173.41

Low
110.45

52 Week Range

High
211.13

Day Low 165.91
Company Name Stock Ticker Symbol Market Type
Repligen Corp RGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.42 -2.00% 167.86 20:00:00
Open Price Low Price High Price Close Price Prev Close
169.82 165.91 173.41 167.86 171.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,620 555,959 $ 168.33 $ 93,586,541 - 110.45 - 211.13
Last Trade Time Type Quantity Stock Price Currency
18:51:09 4 $ 167.70 USD

Repligen Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9.36B 55.77M - 669.33M 41.58M 0.75 225.08
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Repligen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RGEN Message Board. Create One! See More Posts on RGEN Message Board See More Message Board Posts

Historical RGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week165.22174.30152.19162.37579,6302.641.60%
1 Month186.70187.25152.19171.21484,139-18.84-10.09%
3 Months192.05211.13152.19188.22485,546-24.19-12.60%
6 Months140.96211.13110.45171.52595,12126.9019.08%
1 Year166.51211.13110.45165.32588,0571.350.81%
3 Years218.42327.32110.45186.61520,474-50.56-23.15%
5 Years57.39327.3255.44161.11508,419110.47192.49%

Repligen Description

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Your Recent History

Delayed Upgrade Clock